L
Laura D. Locati
Researcher at University of Milan
Publications - 192
Citations - 6143
Laura D. Locati is an academic researcher from University of Milan. The author has contributed to research in topics: Cancer & Head and neck cancer. The author has an hindex of 35, co-authored 170 publications receiving 4810 citations. Previous affiliations of Laura D. Locati include University of Gothenburg.
Papers
More filters
Journal ArticleDOI
Biological agents in head and neck cancer
TL;DR: A comprehensive review of the role of biological agents in head and neck subsites and their molecular characteristics and treatment-relevant signaling pathways is provided.
Journal ArticleDOI
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies.
Carlo Resteghini,Stefano Cavalieri,Alessandro Rametta,Salvatore Alfieri,Donata Galbiati,Francesca Platini,Laura D. Locati,Paolo Bossi,Cristiana Bergamini,Roberta Granata,Ester Orlandi,Cesare Piazza,Moela Mancinelli,Lisa Licitra +13 more
TL;DR: Immunotherapy (IT) provides advantages in a small proportion of recurrent / metastatic head and neck squamous cell carcinoma patients (RM HNSCC) patients (pts).
Journal ArticleDOI
Oral prevalence and clearance of oncogenic human papilloma virus in a rehabilitation community for substance abusers in Italy: a case of behavioral correction?
Davide B. Pugliese,Giacomo Bruzzesi,Caterina Montaldo,Luca Porcu,Marco Landi,Andrea Mastinu,Valter Torri,Lisa Licitra,Laura D. Locati +8 more
TL;DR: A correlation between time spent in the community and increase in the ratio of "low-risk" (LR) HPV and HR-HPV was observed and new HPV infections were detected even in the absence of the recognized and declared risky behavioral factors, suggesting a re-expression from a latent infection.
Journal ArticleDOI
Biological agents in head and neck cancer.
Journal ArticleDOI
TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)
Paolo Bossi,D. Parolini,Cristiana Bergamini,Laura D. Locati,Ester Orlandi,M. Franceschini,Mauro Palazzi,Patrizia Olmi,Paolo Potepan,Lisa Licitra +9 more
TL;DR: TPF followed by cCTRT is feasible in LANPC, and local-regional disease control still remains the main therapeutic goal in this high-stage nonendemic population.